We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.75B
AUM Growth
+$244M
Cap. Flow
+$1.32M
Cap. Flow %
0.05%
Top 10 Hldgs %
34.07%
Holding
425
New
34
Increased
204
Reduced
126
Closed
25

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$27.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.11M
3
XOM icon
ExxonMobil
XOM
+$8.66M
4
UNH icon
UnitedHealth
UNH
+$7.74M
5
NEE icon
NextEra Energy
NEE
+$5.7M

Sector Composition

Rank Sector Weight
1 Technology 25.02%
2 Financials 10.77%
3 Healthcare 10.07%
4 Consumer Discretionary 8.12%
5 Industrials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC.PRL icon
326
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.65B
$487K 0.02%
417
-8
-2% -$9.31K
CL icon
327
Colgate-Palmolive
CL
$74.1B
$460K 0.02%
5,065
-759
-13% -$69.3K
DOW icon
328
Dow Inc
DOW
$21.9B
$459K 0.02%
17,318
-8,250
-32% -$240K
AXS icon
329
AXIS Capital
AXS
$7.62B
$456K 0.02%
4,397
+62
+1% +$6.17K
WBS icon
330
Webster Financial
WBS
$12.8B
$450K 0.02%
8,243
+222
+3% +$11.1K
IJH icon
331
iShares Core S&P Mid-Cap ETF
IJH
$125B
$436K 0.02%
7,025
-4,910
-41% -$288K
SSB icon
332
SouthState Bank Corp
SSB
$10.5B
$435K 0.02%
4,729
+62
+1% +$5.45K
OFIX icon
333
Orthofix Medical
OFIX
$428M
$420K 0.02%
37,625
+503
+1% +$6.23K
HIMS icon
334
Hims & Hers Health
HIMS
$6.87B
$419K 0.02%
8,409
FIX icon
335
Comfort Systems
FIX
$60.3B
$418K 0.02%
779
-796
-51% -$347K
MLM icon
336
Martin Marietta Materials
MLM
$32.3B
$417K 0.02%
759
-8,377
-92% -$4.43M
ONON icon
337
On Holding
ONON
$12.4B
$416K 0.02%
7,990
-217
-3% -$11.1K
CTAS icon
338
Cintas
CTAS
$80.9B
$410K 0.01%
1,839
+69
+4% +$14.9K
HRI icon
339
Herc Holdings
HRI
$5.62B
$408K 0.01%
3,101
-32
-1% -$3.88K
TXRH icon
340
Texas Roadhouse
TXRH
$13.7B
$407K 0.01%
2,173
+572
+36% +$103K
WING icon
341
Wingstop
WING
$3.18B
$407K 0.01%
1,208
+272
+29% +$80.5K
GE icon
342
GE Aerospace
GE
$389B
$405K 0.01%
1,575
WES icon
343
Western Midstream Partners
WES
$19.4B
$400K 0.01%
10,340
IWF icon
344
iShares Russell 1000 Growth ETF
IWF
$127B
$399K 0.01%
3,756
-76
-2% -$7.27K
POST icon
345
Post Holdings
POST
$4.09B
$389K 0.01%
3,568
+1,827
+105% +$205K
ESAB icon
346
ESAB
ESAB
$5.87B
$387K 0.01%
3,208
+42
+1% +$5.08K
PGNY icon
347
Progyny
PGNY
$2.37B
$382K 0.01%
17,369
-228
-1% -$5K
CBLL
348
CeriBell Inc
CBLL
$692M
$381K 0.01%
+20,350
New +$346K
SPTM icon
349
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
$379K 0.01%
5,051
AMAT icon
350
Applied Materials
AMAT
$419B
$373K 0.01%
2,040
+143
+8% +$22.7K

Similar funds

F/M Investments's Q2 2025 Portfolio in Review

As of Q2 2025, F/M Investments held 425 positions worth $2.75B, up 9.7% from $2.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

F/M Investments's Q2 2025 filing shows 34 new, 204 increased, 126 reduced and 25 closed positions. Its largest new stake was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M. The largest sale was Coca-Cola, an estimated $27.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • F/M Investments's largest Q2 2025 buy was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M.
  • F/M Investments added most to F/m US Treasury 3 Month Bill Fund in Q2 2025, an estimated $12M increase.
  • F/M Investments's biggest Q2 2025 reduction was Coca-Cola, cutting an estimated $27.9M.
  • F/M Investments fully exited Thermo Fisher Scientific in Q2 2025, selling an estimated $9.11M.
  • F/M Investments's ten largest holdings make up 34% of its $2.75B portfolio in Q2 2025.
  • F/M Investments opened 34 new positions and closed 25 in Q2 2025.
  • F/M Investments's portfolio value rose 9.7% quarter-over-quarter to $2.75B.

Based on F/M Investments's 13F filing for Q2 2025, filed 13 Aug 2025.